UBA6 and melanoma: Consistent with the Uba6-null melanoma model, Uba6-null 4T1 tumours implanted in NSG mice showed a modest reduction in tumour volume and limited benefit in survival, whereas Uba6-null 4T1 cells did not show any growth disadvantage in vitro (Fig. 5c and Supplementary Fig. 6d, e).